低PD-L1非小细胞肺癌双ICI联合化疗的显著代谢反应

IF 0.8 Q4 RESPIRATORY SYSTEM

Respirology Case Reports Pub Date : 2025-03-16 eCollection Date: 2025-03-01 DOI:10.1002/rcr2.70150

Toshikazu Kumasa, Akina Nigi, Keisuke Iwamoto, Hidetoshi Itani, Shigeto Kondou

引用次数: 0

摘要

尽管PD-L1（程序性死亡配体1）表达较低，但该患者对双重免疫检查点抑制剂和化疗表现出显著的正电子发射断层扫描-计算机断层扫描反应。该病例强调了联合治疗超越传统的基于pd - l1的治疗选择的潜在益处。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Dramatic Metabolic Response to Dual ICI With Chemotherapy in Low PD-L1 NSCLC Case.

Despite low PD-L1 (Programmed Death-ligand 1) expression, this patient exhibited a dramatic positron emission tomography-computed tomography response to dual immune checkpoint inhibitors with chemotherapy. This case highlights the potential benefits of combination therapy beyond traditional PD-L1-based treatment selection.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Respirology Case Reports RESPIRATORY SYSTEM-

CiteScore

1.40

自引率

0.00%

发文量

178

审稿时长

8 weeks

期刊介绍： Respirology Case Reports is an open-access online journal dedicated to the publication of original clinical case reports, case series, clinical images and clinical videos in all fields of respiratory medicine. The Journal encourages the international exchange between clinicians and researchers of experiences in diagnosing and treating uncommon diseases or diseases with unusual presentations. All manuscripts are peer-reviewed through a streamlined process that aims at providing a rapid turnaround time from submission to publication.